EW
Edwards Lifesciences Corp
86.80$
-2.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.0% | 22.0% | 23.8% | 29.1% | 24.9% | 27.1% | 24.0% | 33.1% | 22.6% | 14.9% | 10.0% | 26.3% | |
| 3.0% | 2.6% | 2.4% | 2.4% | 2.1% | 2.1% | 2.4% | 2.6% | 2.6% | 2.4% | 2.9% | 2.6% | |
| 2.1% | 2.0% | 1.9% | 1.8% | 1.9% | 1.9% | 2.1% | 2.1% | 2.4% | 2.3% | 3.0% | 2.6% | |
| -2.5% | -3.0% | -1.2% | 2.7% | 4.6% | 4.6% | 1.2% | -1.5% | -0.9% | – | – | – | |
| 8.2% | 2.6% | 2.2% | 6.8% | -1.1% | -4.7% | 1.0% | 2.8% | -7.8% | -8.8% | -4.8% | 2.5% | |
| 4.0% | 4.3% | 7.3% | 5.1% | 6.5% | 6.4% | 9.3% | 6.3% | 4.9% | 4.4% | 4.6% | 4.3% | |
| -27.3% | -12.7% | -7.1% | -18.8% | 2.1% | -13.7% | -12.1% | -32.9% | 4.7% | 2.9% | 42.5% | -11.7% | |
| 9.7% | 1.3% | 8.6% | 0.0% | 18.5% | 0.4% | 3.2% | 3.0% | 2.7% | 2.8% | – | – | |
| -13.0% | -11.2% | -22.3% | -22.2% | -21.4% | -6.1% | -14.3% | -9.8% | -32.1% | -14.6% | -21.3% | -14.7% | |
| -0.5% | 0.1% | 7.5% | 5.1% | -11.7% | -0.2% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | |
| -6.6% | -6.4% | -9.1% | -13.8% | -29.6% | -2.7% | -11.1% | -6.8% | -29.4% | -11.8% | -18.1% | -15.8% | |
| 10.0% | 2.6% | 7.1% | -3.3% | -2.8% | 10.7% | 0.4% | -6.4% | -1.8% | 6.3% | 35.1% | -2.0% | |
| 40.0% | 17.8% | 16.4% | 24.0% | 18.4% | 20.7% | 14.8% | 26.8% | 17.7% | 10.5% | 5.3% | 22.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.